From November 21 to 23, 2024, the largest annual cardiovascular interventional event in Indonesia—the Indonesian Society of Interventional Cardiology Annual Meeting (ISICAM 2024)—was successfully held. The conference featured academic lectures, live discussions, and surgical broadcasts, attracting renowned experts and scholars from Indonesia, Southeast Asia, China, Japan, and Europe.

ISICAM Highlights 

        The ISICAM 2024 has concluded successfully, themed “Cardiovascular Innovation and Collaboration.” It deeply integrated global advancements in cardiovascular diseases, interventional treatments, minimally invasive surgeries, and imaging technologies.

        Medoo Medical was honored to participate in this event, discussing the latest advancements and technological innovations in the cardiovascular field with experts.

        The Medoo Medical booth became a highlight of the conference. As a leading enterprise in the cardiovascular interventional field, Medoo Medical showcased its flagship products: Mecross CTO, Mecross NC, Mecross HP, Neucross intracranial balloon, Artery Compression Tourniquet, and the soon-to-be-launched Mecross Pro. Many attendees showed great interest and attention to our products, leading to lively interactions on-site.

        As cardiovascular science continues to progress, the related industry is also rapidly developing. To promote comprehensive communication and collaboration between industry, academia, and research, the conference added an industry content section to its academic agenda. Cardiovascular interventional therapy has been a research hotspot in recent years, and the conference invited many internationally renowned experts for engaging keynote speeches, delving into the latest treatment methods and future development trends in cardiovascular diseases, attracting a large audience.

        During the conference, several well-known experts in the field of cardiac intervention visited the Medoo Medical booth to watch and experience demonstrations of our coronary balloon products. They engaged in in-depth discussions about the product functions and clinical data of Medoo Medical’s coronary balloons, providing high praise and recognition.

        This journey to ISICAM 2024 has been immensely rewarding for Medoo Medical, filled with opportunities to engage with top talents in the industry and inspired by the drive for technological advancement. Medoo team will continue to work hard, committed to the innovation and development of global cardiovascular medical devices, contributing more to improving human health.